As of November 6, 2026, Scholar Rock Holding Corporation is a publicly traded company (Nasdaq: SRRK). The largest holder reporting an active stake on Schedule 13D is Samsara BioCapital, L.P., at 7.2%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Passive holders reporting on Schedule 13G include Invus Public Equities, L.P. (8%), Wellington Management (5.6%), T. Rowe Price (5.4%) (Schedule 13D/A, October 7, 2025).
Is this your company?
About to sign with, pay or invest in Scholar Rock Holding Corporation? See the free Snapshot first.
Free to see. No signup.
Is Scholar Rock Holding Corporation a real, registered company?
- Scholar Rock Holding Corporation files with the SEC under CIK 1727196 (its SEC filings).
- Its shares are listed under the ticker SRRK on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Cambridge, Massachusetts, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Scholar Rock Holding Corporation in our court records and SEC 8-K records (as of 2026-11-06).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Invus Public Equities, L.P. (filed 2026-08-13).
Who are Scholar Rock Holding Corporation's owners and officers?
Scholar Rock Holding Corporation: incorporated in Delaware; business address in Cambridge, Massachusetts; industry Biological Products, (No Diagnostic Substances) (Schedule 13G/A, 2026-08-14).
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-08-14 | Redmile Group, LLC | 3.6% |
| Schedule 13G/A, 2026-08-13 | Invus Public Equities, L.P. | 8% |
| Schedule 13G/A, 2026-05-15 | T. Rowe Price Associates, Inc. | 5.4% |
| Schedule 13G/A, 2026-05-15 | Redmile Group, LLC | 7.6% |
| Schedule 13G/A, 2026-03-27 | The Vanguard Group | 0% |
| Schedule 13G, 2026-02-10 | Wellington Management Group LLP | 5.6% |
| Schedule 13G/A, 2025-11-14 | T. Rowe Price Associates, Inc. | 7.2% |
| Schedule 13D/A, 2025-10-07 | Samsara Biocapital, L.P. | 7.2% |
| Schedule 13G/A, 2025-08-14 | T. Rowe Price Associates, Inc. | 9.2% |
Questions about who owns Scholar Rock Holding Corporation
Who owns Scholar Rock Holding Corporation?
On this page, 4 holders' latest ownership filings report 5% or more of Scholar Rock Holding Corporation: Invus Public Equities, L.P. (8%, Schedule 13G/A, filed 2026-08-13), Samsara Biocapital, L.P. (7.2%, Schedule 13D/A, filed 2025-10-07), Wellington Management Group LLP (5.6%, Schedule 13G, filed 2026-02-10) and T. Rowe Price Associates, Inc. (5.4%, Schedule 13G/A, filed 2026-05-15).
Who are the largest shareholders of Scholar Rock Holding Corporation?
By the share each holder's latest filing reports, the largest holders of Scholar Rock Holding Corporation on this page are Invus Public Equities, L.P. (8%), Samsara Biocapital, L.P. (7.2%) and Wellington Management Group LLP (5.6%).
When did Invus Public Equities, L.P. buy into Scholar Rock Holding Corporation?
The filings give report dates, not purchase dates. The earliest filing from Invus Public Equities, L.P. on this page is the Schedule 13G/A, filed 2026-08-13, reporting 8%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 9 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Scholar Rock Holding Corporation?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Scholar Rock Holding Corporation: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Scholar Rock Holding Corporation covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
12 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Which insiders own Scholar Rock Holding Corporation shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- Siren, L.L.C., a 10% owner: 10,825,013 shares (8.9% of shares outstanding), on a joint filing (Form 4, 2026-02-06).
- Invus Global Management, LLC, a 10% owner: 10,825,013 shares (8.9% of shares outstanding), on a joint filing (Form 4, 2026-02-06).
- , a 10% owner: 10,825,013 shares (8.9% of shares outstanding), on a joint filing (Form 4, 2026-02-06).
- , L.P., a 10% owner: 9,250,005 shares (7.6% of shares outstanding), on a joint filing (Form 4, 2024-12-12).
- Invus Public Equities Advisors, LLC, a 10% owner: 9,250,005 shares (7.6% of shares outstanding), on a joint filing (Form 4, 2024-12-12).
Shares outstanding: 121,785,282 as of 2026-08-03, from the company's latest SEC cover page.
How much has Scholar Rock Holding Corporation raised?
No fundraising or offering filing from Scholar Rock Holding Corporation is on file with us.
Keep reading
More on Scholar Rock Holding Corporation and the records around it.
Scholar Rock Holding Corporation elsewhere on the record
- 5%+ stake filings Aug 2026
Companies that share a holder
- Samsara BioCapital, L.P. also filed stake reports on 14 other companies: PMV Pharmaceuticals, Inc. (Sep 2026), Eloxx Pharmaceuticals, Inc. (Aug 2026), RANI THERAPEUTICS HOLDINGS, INC. (May 2026)
- Redmile Group, LLC also filed stake reports on 18 other companies: FATE THERAPEUTICS INC (Nov 2026), Electra Therapeutics, Inc. (Sep 2026), Neurogene Inc. (Aug 2026)
- Invus Public Equities, L.P. also filed stake reports on 24 other companies: City Therapeutics, Inc. (Oct 2026), Yarrow Bioscience, Inc. (Sep 2026), Abivax S.A. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/scholar-rock-holding